$NBIO was recently featured in an article by leading publisher, SmallCapsDaily. The focus of the feature was Nascent Biotech’s development of a drug therapy, with indications for use against pathogens, like the COVID-19 virus, which has spread across the globe, resulting in a pandemic with over 1.3 million cases worldwide. https://finance.yahoo.com/news/nascent-biotec...10983.html